Arneric, Stephen P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Arneric, Stephen P..The latest application filed is for "compositions of a benzenesulfonamide or methylsulfonylbenzene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system".

Company Profile

0.2.14

Arneric, Stephen P. - Milan MI
Arneric, Stephen P. - Portage MI
Arneric; Stephen P. - Lindenhurst IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions of a benzenesulfonamide or methylsulfonylbenzene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system App 20050159471 - Stephenson, Diane T. ; et al.	2005-07-21
Compositions of a phenyl acetic acid cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system App 20050113433 - Stephenson, Diane T. ; et al.	2005-05-26
Compositions of a chromene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system App 20050101629 - Stephenson, Diane T. ; et al.	2005-05-12
Mediated central nervous system compositions of a cyclooxygenase-2 selective inhibitor and a corticotropin releasing factor antagonist for the treatment of ischemic disorders or injury App 20050085479 - Arneric, Stephen P.	2005-04-21
Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders App 20050070524 - Stephenson, Diane T. ; et al.	2005-03-31
Method for treatment of depression and anxiety disorders by combination therapy App 20050059654 - Arneric, Stephen P. ; et al.	2005-03-17
Compositions of a cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system App 20050026919 - Stephenson, Diane T. ; et al.	2005-02-03
Use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinence App 20040248933 - Frail, Donald E. ; et al.	2004-12-09
Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence App 20040248932 - Frail, Donald E. ; et al.	2004-12-09
Use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence App 20040248925 - Frail, Donald E. ; et al.	2004-12-09
Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof App 20040235925 - Arneric, Stephen P.	2004-11-25
Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof App 20040204411 - Arneric, Stephen P.	2004-10-14
Pharmaceutical composition App 20040116533 - Arneric, Stephen P. ; et al.	2004-06-17
Pharmaceutical composition App 20030060513 - Arneric, Stephen P. ; et al.	2003-03-27
3-Pyridyl enantiomers and their use as analgesics Grant 6,133,253 - Holladay , et al. October 17, 2	2000-10-17
Isoxazole, isothiazole and pyrazole compounds that enhance cognitive function Grant 5,409,946 - Garvey , et al. April 25, 1	1995-04-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.